Triple-negative breast cancer (TNBC) is a subtype of breast cancer (BC) that lacks the immunohistochemical expression of the estrogen receptor (ER), the progesterone receptor (PR), and the human epidermal growth factor receptor-2 (HER-2). This evidence concerns the gene ESR1 and breast cancer.